540 related articles for article (PubMed ID: 28652331)
1. DNA methylation markers for diagnosis and prognosis of common cancers.
Hao X; Luo H; Krawczyk M; Wei W; Wang W; Wang J; Flagg K; Hou J; Zhang H; Yi S; Jafari M; Lin D; Chung C; Caughey BA; Li G; Dhar D; Shi W; Zheng L; Hou R; Zhu J; Zhao L; Fu X; Zhang E; Zhang C; Zhu JK; Karin M; Xu RH; Zhang K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7414-7419. PubMed ID: 28652331
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
Ding W; Chen G; Shi T
Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Liu X; Peng Y; Wang J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
[TBL] [Abstract][Full Text] [Related]
4. Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation.
Wang Y; Zhang M; Hu X; Qin W; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22626-22655. PubMed ID: 33202377
[TBL] [Abstract][Full Text] [Related]
5. Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis.
Kim B; Kang S; Jeong G; Park SB; Kim SJ
PLoS One; 2014; 9(5):e97818. PubMed ID: 24842468
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer.
Goldmann T; Schmitt B; Müller J; Kröger M; Scheufele S; Marwitz S; Nitschkowski D; Schneider MA; Meister M; Muley T; Thomas M; Kugler C; Rabe KF; Siebert R; Reck M; Ammerpohl O
Clin Epigenetics; 2021 Feb; 13(1):38. PubMed ID: 33596996
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
11. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
12. CpG methylation signature predicts prognosis in breast cancer.
Du T; Liu B; Wang Z; Wan X; Wu Y
Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide methylation analysis identifies novel prognostic methylation markers in colon adenocarcinoma.
Xue W; Wu X; Wang F; Han P; Cui B
Biomed Pharmacother; 2018 Dec; 108():288-296. PubMed ID: 30223100
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
[TBL] [Abstract][Full Text] [Related]
16. PPIH acts as a potential predictive biomarker for patients with common solid tumors.
Ye J; Ying J; Chen H; Wu Z; Huang C; Zhang C; Chen Z; Chen H
BMC Cancer; 2024 Jun; 24(1):681. PubMed ID: 38834966
[TBL] [Abstract][Full Text] [Related]
17. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
18. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.
Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S
Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250
[TBL] [Abstract][Full Text] [Related]
19. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
20. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
Kaur H; Bhalla S; Raghava GPS
PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
